MYRIAD GENETICS, INC. Unrecognized Tax Benefits
MYRIAD GENETICS, INC. (MYGN) had Unrecognized Tax Benefits of $22.10 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-02-24
- 2025-12-31: Unrecognized Tax Benefits $22.10M.
- 2024-12-31: Unrecognized Tax Benefits $51.70M.
- 2023-12-31: Unrecognized Tax Benefits $48.10M.
- 2022-12-31: Unrecognized Tax Benefits $43.90M; Unrecognized Tax Benefits as first filed $31.90M.
| Period end | Unrecognized Tax Benefits | Unrecognized Tax Benefits as first filed |
|---|---|---|
| 2025-12-31 | $22.10M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $51.70M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $48.10M 10-K · filed 2026-02-24 | |
| 2022-12-31 | $43.90M 10-K · filed 2026-02-24 | $31.90M 10-K · filed 2023-03-01 |
| 2022-09-30 | $27.90M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $27.70M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $28.00M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $32.10M 10-K · filed 2025-02-28 | |
| 2021-09-30 | $32.00M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $31.00M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $30.80M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $37.60M 10-K · filed 2024-02-28 | |
| 2020-09-30 | $37.40M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $23.50M 10-K · filed 2023-03-01 | |
| 2020-03-31 | $22.30M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $22.40M 10-Q · filed 2020-02-07 | |
| 2019-09-30 | $22.10M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $21.70M 10-K · filed 2023-03-01 | |
| 2019-03-31 | $19.90M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $24.90M 10-Q · filed 2019-02-06 | |
| 2018-09-30 | $24.60M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $24.90M 10-K · filed 2022-02-25 | |
| 2018-03-31 | $27.90M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $33.40M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $31.90M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $25.20M 10-KT · filed 2021-03-16 | |
| 2017-03-31 | $24.90M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $24.60M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $24.40M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $24.00M 10-K · filed 2017-08-09 | |
| 2016-03-31 | $24.00M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $27.90M 10-Q · filed 2016-02-03 | |
| 2015-09-30 | $27.20M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $26.40M 10-K · filed 2016-08-10 | |
| 2015-03-31 | $26.11M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $25.33M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $24.51M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $24.20M 10-K · filed 2015-08-12 | $24.24M 10-K · filed 2014-08-13 |
| 2014-03-31 | $13.64M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $13.32M 10-Q · filed 2014-02-05 | |
| 2013-09-30 | $12.36M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $10.72M 10-K · filed 2014-08-13 | |
| 2013-03-31 | $10.48M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $10.14M 10-Q · filed 2013-02-06 | |
| 2012-09-30 | $10.14M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $10.01M 10-K · filed 2013-08-14 | |
| 2012-03-31 | $10.01M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $9.45M 10-Q · filed 2012-02-01 | |
| 2011-09-30 | $9.45M 10-Q · filed 2011-11-02 | |
| 2011-06-30 | $9.65M 10-K · filed 2012-08-15 | |
| 2011-03-31 | $9.45M 10-Q · filed 2011-05-04 | |
| 2010-12-31 | $9.32M 10-Q · filed 2011-02-01 | |
| 2010-09-30 | $8.80M 10-Q · filed 2010-11-03 | |
| 2010-06-30 | $8.80M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |